Back
ESC Professional Premium Access

Periprocedural outcomes of transcatheter aortic valve replacement (TAVR) in patients with and without cardiac amyloidosis-analysis from 2016-2019 national inpatient sample

Session: When valvular heart disease is not alone
Topic: Intervention
Speaker: Doctor S. Kambalapalli (Flint, US)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Soumya Kambalapalli

McLaren Flint Michigan State University, Flint (United States of America)
0 follower

6 more presentations in this session

Echocardiographic phenotype in severe aortic valve stenosis with and without cardiac amyloidosis: the AMY-TAVI trial.

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access
Abstract
Slides
Thumbnail

Diagnostic performance of coronary CTA and CT-FFR for the detection of coronary artery disease in routine TAVI work-up

Speaker: Ms J. Peper (Nieuwegein, NL)

Access
Abstract
Slides
Thumbnail

Revascularization of significant coronary artery disease in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Speaker: Mr H. Aarts (Utrecht, NL)

Access
Abstract
Slides
Thumbnail

Adding troponin to echocardiography improves preoperative abscess detection in infective endocarditis. A REMOVE Trial analysis

Speaker: Doctor M. Diab (Rotenburg An Der Fulda, DE)

Access
Abstract
Slides
Thumbnail

Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis

Speaker: Doctor W. Jaber (Cleveland, US)

Access
Abstract
Slides
Thumbnail

Access the full session

When valvular heart disease is not alone

Speakers: Doctor S. Kambalapalli, Professor J. Gonzalez Juanatey, Ms J. Peper, Mr H. Aarts, Doctor M. Diab...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb